Construction of a fluoxetine ion chemical sensor and its application for the determination of pKa value of fluoxetine conjugated acid, complexation study with β-cyclodextrin and formulations assay

Analytical Letters

Volumn 43, Issue 14, 2010, Pages 2171-2183

  Papas, Emmanuel S ^a   Chaldezos, Constantinos N ^a   Atta Politou, Julia ^a   Koupparis, Michael A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cyclodextrin complexation; Dissociation constant; Fluoxetine; Fluoxetine sensor; Ion selective electrode; Pharmaceutical analysis

Indexed keywords

EID: 77955642210     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032711003687104     Document Type: Article

References (35)

1. Afkami, A., T. Madrakian, and L. Khalafi. 2006. Spectophotometric determination of fluoxetine by batch and flow injection methods. Chem. Pharm. Bull. 54(12): 1642-1646
2. Ali, S. M., F. Asmat, A. Maheshwari, and M. Koketsu. 2005. Complexation of fluoxetine with β-cyclodextrin. A proton magnetic resonance study in aqueous solution. Il Farmaco 60(5): 445-449.
3. Angelakou, A., G. Valsami, M. A. Koupparis, and P. E. Macheras. 1993. Use of 1-anilino-8 naphthalenesulfonate as an ion probe for the potentiometric study of the binding of sulfonamides to bovine serum albumin and plasma. J. Pharm. Pharmacol. 45(5): 434-438
4. Atta-Politou, J., M. Koupparis, and P. Macheras. 1996. Development of a potentiometric kinetic method for drug adsorption studies: The chlorpromazine - charcoal model case. Eur. J. Pharm. Sci. 4(4): 223-230.
5. Atta-Politou, J., P. Macheras, and M. Koupparis. 1996. The effect of polyethylene glycol on the charcoal adsorption of chlorpromazine studied by ion selective electrode potentiometry. J. Toxicol. Clin. Toxicol. 34(3): 307-316.
6. Atta-Politou, J., I. Skopelitis, I. Apatsidis, and M. Koupparis. 2001. In vitro study on fluox- etine adsorption onto charcoal using potentiometry. Eur. J. Pharm. Sci. 12(3): 311-319
7. Benfield, P., R. C. Heel, and S. P. Lewis. 1986. Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties. Drugs 32(6): 481-508.
8. Berzas, J. J., A. Alanon, and J. A. Lazaro. 2002. Cyclodextrin enhanced spectrofluorimetric determination of fluoxetine in pharmaceuticals and biological fluids. Talanta 58(2): 301-309.
9. Berzas-Nevado, J. J., M. J. Villasensor-Llerena, A. M. Contento-Salcedo, and E. Aguas-Nuevo. 2000. Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography. J. Chromatogr. Sci. 38(5): 200-206.
10. British Pharmacopoeia. 2001. vol. II, 2096-2097. The Stationary Office. Market Towers, 1 Nine Elms Lane, London, England.
11. Chen, S. T., R. C. Thompson, and R. I. Poust. 1981. Measurement of pseudoephedrine hydrochloride dissolution using chloride-ion electrode. J. Pharm. Sci. 70(11): 1288-1289.
12. Cooney, D. O., and R. Thomason. 1997. Adsorption of fluoxetine HCL by activated charcoal. J. Pharm. Sci. 86(5): 642-644.
13. Council of Europe, European Pharmacopoeia, 6th Edition 2008, p. 1922, Strasbourg, 2008
14. Craggs, A., G. J. Moody, and J. D. Thomas. 1974. PVC matrix membrane ion selective electrodes. J. Chem. Educ. 51(8): 541-544.
15. Efstathiou, C. E., M. A. Koupparis, and T. P. Hadjiioannou. 1985. Applications of ion - selective electrodes in reaction kinetics and kinetic analysis. Ion-Sel. Rev. 7(2): 203-259
16. Eli Lilly and Company. 2005. Fluoxetine Hydrochloride Oral Solution. Material Safety Data Sheet. Lilly Corporate Center, Indianapolis, IN, USA.
17. Fromming, K. H., and K. H. J. Szejtli. 1994. Chapter 4: Cyclodextrin inclusion complexes, pp. 45-81 and Chapter 8: Cyclodextrins in various drug formulations, pp. 151-193, In Cyclodextrins in Pharmacy. Dordrecht: Kluwer Academic Publishers.
18. Harris, M. G., and P. Benfield. 1995. Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in older patients with depressive illness. Drugs Aging 6(1): 64-84.
19. Lacroix, P. M., P. N. Yat, and E. G. Lovering. 1995. Liquid chromatographic methods for fluoxetine hydrochloride, its meta isomer and related compounds in raw material. J. AOAC Int. 78(2): 334-339.
20. Li, Y. S. 2001. Fluoxetine chemical sensor based on polyvinyl chloride - urushind resins. Fenxi- Huaxue 29(6): 737.
21. Mitsana-Papazoglou, A., T. K. Christopoulos, E. P. Diamandis, and M. A. Koupparis. 1987. Dissolution studies of drug formulations using ion - selective electrodes as sensors in an air segmented continuous flow analyzer. J. Pharm. Sci. 76(9): 724-730.
22. Panagos, D. S., and M. A. Koupparis. 1995. Construction of an iopanoic acid ion - selective electrode and its application to pharmaceutical analysis. Analyst 120(6): 1643-1646
23. Prabhakar, A. H., V. B. Patel, and R. J. Giridhar. 1999. Spectrophotometric determination of fluoxetine hydrochloride in bulk and in pharmaceutical formulations. J. Pharm. Biomed. Anal. 20(3): 427-432.
24. Pramar, Y., V. D. Dasgupta, and C. Bethea. 1992. Quantitation of fluoxetine hydrochloride in capsules using high performance liquid chromatography. Drug Dev. Ind. Pharm. 18(2): 257-264.
25. Raggi, M. A., G. Casamenti, R. Mandrioli, C. Sabbioni, and V. Volterra. 2000. A rapid LC method for the analysis of CNS drugs in pharmaceutical formulations. J. Pharm. Biomed. Anal. 23(1): 161-167.
26. Sanders-Bush, E., and S. E. Mayer. 5-hydroxytryptamine (serotonin) receptor agonists and antagonists. In Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th Ed., ed. J. G. Hardman and L. E. Limbird, 258. New York: McGraw-Hill.
27. Sideris, E. E. M., A. Koupparis, and P. E. Macheras. 1994. Effect of cyclodextrins on protein binding of drugs: The diflunisal hydroxypropyl - β-cyclodextrin model case. Pharm. Res. 11(1): 90-95.
28. Solich, P., P. Macheras, and M. A. Koupparis. 1995. Construction of a diflunisal ion sensor and its use in automated flow - injection methods for assay, content uniformity and dissolution studies of formulations. J. Pharm. Sci. 84(7): 889-894.
29. Sommi, R. W., L. M. Crimson, and C. L. Bowden. 1987. Fluoxetine - A serotonin - specific, 2nd - generation antidepressant. Pharmacotherapy 7(1): 1-15.
30. Sousa, F. B., A. M. Leite Denadai, I. S. Lula, J. F. Lopes, H. F. Dos Antos, W. B. Almeida, and R. D. Sinistera. 2008. Supramolecular complex of fluoxetine with β-cyclodextrin: An experimental and theoretical study. Int. J. Pharma. 353(1-2): 160-169
31. Valsami, G. N., P. E. Macheras, and M. A. Koupparis. 1990. Binding studies of ions with cyclodextrins using ion selective electrodes. J. Pharm. Sci. 79(12): 1087-1094.
32. Valsami, G. N., P. E. Macheras, and M. A. Koupparis. 1991. Binding study of the fluorescence probe 1-anilino-8 naphthalenesulfonate tas an ion probe for the potentiometric study of the binding of sulfonamides to human plasma and human and bovine serum albumin using potentiometric titration. Pharm. Res. 8(7): 888-892
33. Valsami, G. N., M. A. Koupparis, and P. E. Macheras. 1992. Complexation studies of cyclodextrins with tricyclic antidepressants using ion selective electrodes. Pharm. Res. 9(1): 94-100.
34. Veltsistas, P. G., M. I. Karayannis, and M. A. Koupparis. 1994. Potentiometric determination of p - chloranil and the kinetic study of its alkaline hydrolysis using a chloranilate selective electrode. Talanta 41(10): 1725-1733.
35. Yilmaz, N., Y. Ozkan, S. A. Ozan, I. Biryol, and H. Y. Aboul-Enein. 2000. High performance liquid chromatographic assay and drug dissolution studies of fluoxetine hydrochloride in capsule formulations. J. Liq. Chromatogr. Relat. Technol. 23(11): 1699-1710.